NEWRON PHARMACEUT. EO-20 (NP5) — Net Asset Momentum
NEWRON PHARMACEUT. EO-20 (NP5) recorded a net asset momentum of 104.9% as of December 2024, with net assets of €1.46 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See NEWRON PHARMACEUT. EO-20 (NP5) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
NEWRON PHARMACEUT. EO-20 Net Asset Momentum (2005–2024)
This chart tracks NEWRON PHARMACEUT. EO-20's year-over-year net asset growth across 20 annual reporting periods from 2005 to 2024. The most recent momentum reading is +104.9%, with net assets of €1.46 Million EUR as of December 2024. Read NEWRON PHARMACEUT. EO-20 (NP5) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for NEWRON PHARMACEUT. EO-20 (2005–2024)
The table below shows the complete annual net asset history for NEWRON PHARMACEUT. EO-20 from 2005 to 2024, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see NP5 company net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €1.46 Million | €63.91 Million | €62.45 Million | ▲ +104.9% |
| 2023 | €-29.91 Million | €25.87 Million | €55.77 Million | ▼ -113.2% |
| 2022 | €-14.03 Million | €37.20 Million | €51.23 Million | ▼ -551.6% |
| 2021 | €3.11 Million | €50.49 Million | €47.38 Million | ▼ -82.0% |
| 2020 | €17.25 Million | €51.20 Million | €33.95 Million | ▼ -53.1% |
| 2019 | €36.80 Million | €60.29 Million | €23.49 Million | ▼ -32.9% |
| 2018 | €54.84 Million | €60.00 Million | €5.16 Million | ▼ -19.0% |
| 2017 | €67.72 Million | €73.02 Million | €5.30 Million | ▲ +36.1% |
| 2016 | €49.75 Million | €56.59 Million | €6.84 Million | ▲ +34.0% |
| 2015 | €37.11 Million | €44.38 Million | €7.27 Million | ▲ +26.8% |
| 2014 | €29.26 Million | €37.07 Million | €7.81 Million | ▲ +38.7% |
| 2013 | €21.09 Million | €31.62 Million | €10.53 Million | ▼ -23.6% |
| 2012 | €27.61 Million | €44.65 Million | €17.04 Million | ▲ +319.3% |
| 2011 | €6.58 Million | €13.57 Million | €6.98 Million | ▼ -46.0% |
| 2010 | €12.19 Million | €19.13 Million | €6.94 Million | ▼ -58.4% |
| 2009 | €29.28 Million | €41.68 Million | €12.39 Million | ▼ -36.1% |
| 2008 | €45.81 Million | €60.54 Million | €14.73 Million | ▼ -20.2% |
| 2007 | €57.40 Million | €70.37 Million | €12.97 Million | ▼ -15.4% |
| 2006 | €67.86 Million | €86.16 Million | €18.30 Million | ▲ +298.7% |
| 2005 | €17.02 Million | €23.50 Million | €6.48 Million | — |